scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0006-2952(03)00211-9 |
P698 | PubMed publication ID | 12907238 |
P2093 | author name string | Bhalchandra A Diwan | |
David Kritchevsky | |||
Lucy M Anderson | |||
Richard J Calvert | |||
Shirley Tepper | |||
P2860 | cites work | Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse | Q28252945 |
The role of mitogen-activated protein (MAP) kinase in breast cancer | Q30308930 | ||
Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer | Q33885599 | ||
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering | Q33912099 | ||
K-ras p21 expression and activity in lung and lung tumors | Q34150023 | ||
'Smoke like a man, die like a man'?: a review of the relationship between gender, sex and lung cancer | Q34369585 | ||
Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking | Q34503196 | ||
Serum cholesterol and cancer risk: an epidemiologic perspective | Q35706361 | ||
Cholestyramine promotes 7,12-dimethylbenzanthracene induced mammary cancer in Wistar rats | Q36027903 | ||
Statin use, hyperlipidaemia, and the risk of breast cancer | Q36644431 | ||
Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase | Q37024891 | ||
Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity | Q37108753 | ||
Wildtype Kras2 can inhibit lung carcinogenesis in mice | Q40783010 | ||
Levels and membrane localization of the c-K-ras p21 protein in lungs of mice of different genetic strains and effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and Aroclor 1254. | Q41055103 | ||
Differential distribution and increased levels of ras proteins during lung development | Q42529083 | ||
Characterization of skin tumor promotion by mirex: structure-activity relationships, sexual dimorphism and presence of Ha-ras mutation | Q42558185 | ||
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin | Q43604509 | ||
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women | Q43852393 | ||
Decrease in K-ras p21 and increase in Raf1 and activated Erk 1 and 2 in murine lung tumors initiated by N-nitrosodimethylamine and promoted by 2,3,7,8-tetrachlorodibenzo-p-dioxin | Q43909292 | ||
Statin use and the risk of breast and prostate cancer | Q43966555 | ||
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project | Q44000674 | ||
Alterations in membrane-bound and cytoplasmic K-ras protein levels in mouse lung induced by treatment with lovastatin, cholestyramine, or niacin: effects are highly mouse strain dependent | Q44054370 | ||
Mice expressing the human CYP7A1 gene in the mouse CYP7A1 knock-out background lack induction of CYP7A1 expression by cholesterol feeding and have increased hypercholesterolemia when fed a high fat diet | Q44119079 | ||
The lovastatin-treated rodent: a new model of barrier disruption and epidermal hyperplasia | Q46057741 | ||
Mechanisms of gender-specific TCDD-induced toxicity in guinea pig adipose tissue | Q46102619 | ||
Effect of cholesterol and cholestyramine feeding and of fasting on sterol synthesis in the liver, lleum, and lung of the guinea pig | Q46718420 | ||
Pituitary grafts modify sex differences in liver tumor formation in the rat following initiation with diethylnitrosamine and different promotion regimens | Q48337586 | ||
Differences in lung cancer risk between men and women: examination of the evidence. | Q51032996 | ||
Chemoprevention by pravastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, of N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats. | Q53452219 | ||
High lovastatin doses combined with hypercholesterolemic diet induce hepatic damage and are lethal to the CD-1 mouse. | Q54091965 | ||
Influence of age and gender on the plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitory activity following multiple doses of lovastatin and simvastatin | Q67994624 | ||
Diet-induced reduction in serum lipoproteins stimulates cell proliferation in weanling rats | Q69398694 | ||
A rat model for studying colonic cancer: Effect of cholestyramine on induced tumors | Q69638008 | ||
Variation in susceptibility to atherosclerosis among inbred strains of mice | Q69805944 | ||
Inhibition of ras p21 membrane localization and modulation of protein kinase C isozyme expression during regression of chemical carcinogen-induced murine skin tumors by lovastatin | Q72182671 | ||
AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet | Q72577338 | ||
Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin | Q73040935 | ||
Chemoprevention of lung cancer by lycopene | Q73584202 | ||
SERUM CHOLESTEROL LEVELS OF INBRED RATS | Q76986711 | ||
Preclinical and clinical models of lung cancer chemoprevention | Q77793491 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | niacinamide | Q192423 |
P304 | page(s) | 393-403 | |
P577 | publication date | 2003-08-01 | |
P1433 | published in | Biochemical Pharmacology | Q864229 |
P1476 | title | Treatment with lovastatin, cholestyramine or niacin alters K-ras membrane association in mouse lung in a strain-dependent manner: results in females | |
P478 | volume | 66 |
Q35745160 | Elevated K-ras activity with cholestyramine and lovastatin, but not konjac mannan or niacin in lung--importance of mouse strain |
Q44904792 | Mevalonate promotes the growth of tumors derived from human cancer cells in vivo and stimulates proliferation in vitro with enhanced cyclin-dependent kinase-2 activity |
Q36765168 | Plasma membrane regulates Ras signaling networks |
Search more.